Latest Biotech News

Innovative approaches in neuroscience include graphene-mediated optical stimulation to accelerate maturation of human brain organoids, facilitating modeling of Alzheimer's and other age-related...

Quanterix secured New York State CLIA permit for its Accelerator Laboratory, now fully certified across all U.S. states, enhancing access to neurodegenerative disease assays. Novel fluorescent...

Continuous biomanufacturing is maturing with demonstrated productivity gains, cost reductions, and facility footprint improvements prompting wider adoption globally. Digital twins modeling...

Cutting-edge research explores new therapeutic modalities and mechanisms contributing to cancer treatment resistance. A novel nomogram integrating clinical and blood biomarkers predicts lung...

Researchers report transformative technologies in molecular biosciences. The S²ALM AI antibody language model revolutionizes antibody engineering. Methods that integrate single-cell proteomics...

Efforts to enhance clinical trial accessibility and healthcare equity gain momentum. Over 130 organizations back the Clinical Trial Modernization Act to broaden patient participation and financial...

Breakthroughs in environmental and agricultural sectors showcase biotechnology’s expanding impact. Researchers identify a new bacterial enzyme class capable of reducing potent greenhouse gas...

Researchers at UC San Diego have developed a novel graphene-mediated optical stimulation (GraMOS) method that accelerates the maturation of human brain organoids. This non-genetic, biocompatible...

Gilead Sciences has acquired Interius BioTherapeutics for $350 million, gaining a platform for in vivo CAR-T cell therapies. This single-shot approach potentially allows genetic modification of...

Ionis Pharmaceuticals received FDA approval for Dawnzera (donidalorsen), a prophylactic therapy targeting hereditary angioedema (HAE), a rare and potentially life-threatening genetic disorder...

Sarepta Therapeutics announced refinancing transactions that delay approximately $700 million of convertible senior notes due in 2027, extending maturities to 2030 and beyond. This move...

A collaborative study involving the University of Pittsburgh and University College London reveals that the human brain’s cortical body maps remain remarkably stable even years after arm...

Multiple studies highlight AI’s transformative role in healthcare diagnostics. New AI models predict tumor microRNA expression in kidney cancer and pulmonary hemorrhage in preterm infants....

Innovative cancer research reveals mechanisms and therapies reshaping oncology. Bispecific innate cell engager AFM28 targets CD123+ leukemic stem cells in AML and MDS, offering new immunotherapy...

The FDA’s expedited review for Stealth BioTherapeutics’ Barth syndrome therapy signals a regulatory shift benefiting rare disease treatments. Following multiple delays and rejections, a planned...

Recent breakthroughs shed light on metabolic and immune pathways in cancer. Targeting spermine metabolism enhances pancreatic cancer immunity, potentially improving immunotherapies. Meanwhile,...

Researchers at the University of California, San Diego Sanford Stem Cell Institute have developed a groundbreaking Graphene-Mediated Optical Stimulation (GraMOS) technique that uses graphene's...

Gilead Sciences’ subsidiary Kite Pharma has acquired Interius BioTherapeutics for $350 million, gaining proprietary in vivo CAR-T cell therapy technology that enables genetic modification of...

Ionis Pharmaceuticals achieved FDA approval for Dawnzera (donidalorsen), a prophylactic treatment for hereditary angioedema (HAE), marking its second rare disease approval within a year. The...

Cutting-edge AI technologies continue to revolutionize biotechnology, as exemplified by several breakthroughs. MIT researchers developed a generative AI model that proposed over 10 million novel...